# EDGAR Filing Document

**Accession Number:** 0000866706
**File Stem:** 0001410578-25-001667
**Filing Date:** 2025-8
**Character Count:** 99272
**Document Hash:** 7419216943f04d267157d17112b2f157
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410578-25-001667.hdr.sgml**: 20250811

**ACCESSION NUMBER**: 0001410578-25-001667

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 68

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250811

**DATE AS OF CHANGE**: 20250811

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ESCO TECHNOLOGIES INC
- **CENTRAL INDEX KEY:** 0000866706
- **STANDARD INDUSTRIAL CLASSIFICATION:** COMMUNICATIONS EQUIPMENT, NEC [3669]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 431554045
- **STATE OF INCORPORATION:** MO
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10596
- **FILM NUMBER:** 251201031

**BUSINESS ADDRESS:**
- **STREET 1:** 645 MARYVILLE CENTRE DR., SUITE 300
- **CITY:** ST. LOUIS
- **STATE:** MO
- **ZIP:** 63141
- **BUSINESS PHONE:** 3142137200

**MAIL ADDRESS:**
- **STREET 1:** 645 MARYVILLE CENTRE DR., SUITE 300
- **CITY:** ST. LOUIS
- **STATE:** MO
- **ZIP:** 63141

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ESCO ELECTRONICS CORP
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? ESCO TECHNOLOGIES INC._JUNE 30, 2025

------

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2025

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TO &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

COMMISSION FILE NUMBER 1-10596

ESCO TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| MISSOURI | 43-1554045 |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification No.) |
| 645 MARYVILLE CENTRE DR., SUITE 300 |  |
| ST. LOUIS, MISSOURI | 63141-5855 |
| (Address of principal executive offices) | (Zip Code) |

---

(314) 213-7200

(Registrant's telephone number, including area code)

Securities registered pursuant to section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share | ESE | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒ Accelerated filer ☐ <br> Non-accelerated filer ☐ Smaller reporting company ☐ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

---

| | |
|:---|:---|
| **Class** | **Shares outstanding at July 31, 2025** |
| Common stock, $.01 par value per share | 25824688 |

---

------

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Dollars in thousands, except per share amounts)

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  |
|  | **June 30,**  | **June 30,**  |
|  | **2025** | **2024** |
| Net sales | $296344 | 233568 |
| Costs and expenses: |  |  |
| &nbsp;&nbsp;Cost of sales | 174350 | 135373 |
| &nbsp;&nbsp;Selling, general and administrative expenses | 62042 | 51013 |
| &nbsp;&nbsp;Amortization of intangible assets | 16753 | 8145 |
| &nbsp;&nbsp;Interest expense, net | 7921 | 3335 |
| &nbsp;&nbsp;Other expenses (income), net | 2209 | (264) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total costs and expenses | 263275 | 197602 |
| Earnings before income taxes | 33069 | 35966 |
| Income tax expense | 8314 | 7654 |
| &nbsp;&nbsp;Earnings from continuing operations | 24755 | 28312 |
| Earnings from discontinued operations, net of tax expense of $599 and $288 | 1310 | 918 |
| &nbsp;&nbsp;Net earnings | $26065 | 29230 |
| Earnings per share: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic – Continuing operations | $0.96 | 1.10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– Discontinued operations | 0.05 | 0.04 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– Net earnings | $1.01 | 1.14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted – Continuing operations | 0.96 | 1.10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– Discontinued operations | 0.05 | 0.03 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– Net earnings | $1.01 | 1.13 |

---

See accompanying notes to condensed consolidated financial statements.

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Dollars in thousands, except per share amounts)

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended**  | **Nine Months Ended**  |
|  | **June 30,**  | **June 30,**  |
|  | **2025** | **2024** |
| Net sales | $742714 | 645621 |
| Costs and expenses: |  |  |
| &nbsp;&nbsp;Cost of sales | 431068 | 378427 |
| &nbsp;&nbsp;Selling, general and administrative expenses | 171305 | 152607 |
| &nbsp;&nbsp;Amortization of intangible assets | 32735 | 24585 |
| &nbsp;&nbsp;Interest expense, net | 12373 | 9228 |
| &nbsp;&nbsp;Other expenses, net | 1947 | 404 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total costs and expenses | 649428 | 565251 |
| Earnings before income taxes | 93286 | 80370 |
| Income tax expense | 21841 | 17040 |
| &nbsp;&nbsp;Earnings from continuing operations | 71445 | 63330 |
| Earnings from discontinued operations, net of tax expense of $3,006 and $1,189 | 9126 | 4288 |
| &nbsp;&nbsp;Net earnings | $80571 | 67618 |
| Earnings per share: |  |  |
| &nbsp;&nbsp;Basic – Continuing operations | 2.77 | 2.46 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– Discontinued operations | $0.35 | 0.16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– Net earnings | 3.12 | 2.62 |
| &nbsp;&nbsp;Diluted – Continuing operations | 2.76 | 2.46 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– Discontinued operations | 0.35 | 0.16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– Net earnings | $3.11 | 2.62 |

---

See accompanying notes to condensed consolidated financial statements.

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(Dollars in thousands)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  | **Nine Months Ended**  | **Nine Months Ended**  |
|  | **June 30,**  | **June 30,**  | **June 30,**  | **June 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Net earnings | $26065 | 29230 | 80571 | 67618 |
| Other comprehensive income (loss), net of tax: |  |  |  |  |
| &nbsp;&nbsp;Foreign currency translation adjustments | 23075 | (1001) | 13180 | 3668 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income (loss), net of tax | 23075 | (1001) | 13180 | 3668 |
| Comprehensive income | $49140 | 28229 | 93751 | 71286 |

---

See accompanying notes to condensed consolidated financial statements.

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(Dollars in thousands)

---

| | | |
|:---|:---|:---|
|  | **June 30,** <br>**2025** | **September 30,** <br>**2024** |
| ASSETS |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $78716 | 65963 |
| &nbsp;&nbsp;Accounts receivable, net of allowance for credit losses of $3,307 and $2,734, respectively | 238022 | 222101 |
| &nbsp;&nbsp;Contract assets | 91727 | 66712 |
| &nbsp;&nbsp;Inventories | 237110 | 195465 |
| &nbsp;&nbsp;Other current assets | 32596 | 21027 |
| &nbsp;&nbsp;Assets held for sale – current | 76552 | 97381 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 754723 | 668649 |
| Property, plant and equipment, net of accumulated depreciation of $182,511 and $171,444, respectively | 167236 | 149251 |
| Intangible assets, net of accumulated amortization of $266,382 and $234,281, respectively | 745079 | 403524 |
| Goodwill | 760555 | 529935 |
| Operating lease assets | 46796 | 37476 |
| Other assets | 17208 | 13791 |
| Assets held for sale – other | 34788 | 35994 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2526385 | 1838620 |
| LIABILITIES AND SHAREHOLDERS' EQUITY |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;Current maturities of long-term debt | $20000 | 20000 |
| &nbsp;&nbsp;Accounts payable | 86209 | 88936 |
| &nbsp;&nbsp;Contract liabilities | 205591 | 80844 |
| &nbsp;&nbsp;Accrued salaries | 45017 | 41768 |
| &nbsp;&nbsp;Accrued other expenses | 65518 | 55807 |
| &nbsp;&nbsp;Liabilities held for sale – current | 74505 | 62499 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 496840 | 349854 |
| Deferred tax liabilities | 115023 | 72623 |
| Non-current operating lease liabilities | 43633 | 34810 |
| Other liabilities | 36500 | 39273 |
| Long-term debt | 505000 | 102000 |
| Liabilities held for sale – other | 2775 | 2710 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1199771 | 601270 |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;Preferred stock, par value $.01 per share, authorized 10,000,000 shares |  |  |
| &nbsp;&nbsp;Common stock, par value $.01 per share, authorized 50,000,000 shares, issued 30,881,459 and 30,809,483 shares, respectively | 309 | 308 |
| &nbsp;&nbsp;Additional paid-in capital | 313649 | 311942 |
| &nbsp;&nbsp;Retained earnings | 1157325 | 1082950 |
| &nbsp;&nbsp;Accumulated other comprehensive income (loss), net of tax | 2406 | (10775) |
|  | 1473689 | 1384425 |
| &nbsp;&nbsp;Less treasury stock, at cost: 5,056,771 and 5,056,771 common shares, respectively | (147075) | (147075) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 1326614 | 1237350 |
| Total liabilities and shareholders' equity | $2526385 | 1838620 |

---

See accompanying notes to condensed consolidated financial statements.

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(Dollars in thousands)

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended**  | **Nine Months Ended**  |
|  | **June 30,**  | **June 30,**  |
|  | **2025** | **2024** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;Net earnings | $80571 | 67618 |
| &nbsp;&nbsp;Adjustments to reconcile net earnings to net cash provided (used) by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(Earnings) loss from discontinued operations, net of tax | (9126) | (4288) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 48401 | 38972 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expense | 7934 | 6369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities | (33473) | (39275) |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of deferred taxes  | (6008) | (6302) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities – continuing operations | 88299 | 63094 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided (used) by operating activities – discontinued operations | 43703 | (7640) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 132002 | 55454 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;Acquisition of business, net of cash acquired | (472006) | (56383) |
| &nbsp;&nbsp;Capital expenditures | (24210) | (19551) |
| &nbsp;&nbsp;Additions to capitalized software and other | (13018) | (8515) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used by investing activities – continuing operations | (509234) | (84449) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used by investing activities – discontinued operations | (966) | (5439) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used by investing activities | (510200) | (89888) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;Proceeds from long-term debt  | 645000 | 193000 |
| &nbsp;&nbsp;Principal payments on long-term debt and short-term borrowings | (242000) | (122000) |
| &nbsp;&nbsp;Purchases of common stock into treasury |  | (7998) |
| &nbsp;&nbsp;Dividends paid | (6196) | (6185) |
| &nbsp;&nbsp;Other | (6205) | (1516) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities – continuing operations | 390599 | 55301 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities – discontinued operations |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 390599 | 55301 |
| Effect of exchange rate changes on cash and cash equivalents | 452 | 309 |
| Net increase in cash and cash equivalents | 12853 | 21176 |
| Cash and cash equivalents, beginning of period | 65963 | 41866 |
| Cash and cash equivalents, end of period | $78816 | 63042 |
| Supplemental cash flow information: |  |  |
| &nbsp;&nbsp;Interest paid | $16038 | 8430 |
| &nbsp;&nbsp;Income taxes paid (including state and foreign) | 29059 | 25952 |

---

See accompanying notes to condensed consolidated financial statements.

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1.&nbsp;&nbsp;&nbsp;&nbsp;BASIS OF PRESENTATION

The accompanying condensed consolidated financial statements, in the opinion of management, include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the results for the interim periods presented. The condensed consolidated financial statements are presented in accordance with the requirements of Form 10-Q and consequently do not include all the disclosures required for annual financial statements by accounting principles generally accepted in the United States of America (GAAP). For further information refer to the consolidated financial statements and related notes included in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2024.

The Company's results for the three-month period ended June 30, 2025 are not necessarily indicative of the results for the entire 2025 fiscal year. References to the third quarters of 2025 and 2024 represent the fiscal quarters ended June 30, 2025 and 2024, respectively. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities. Actual results could differ from those estimates.

2.&nbsp;&nbsp;&nbsp;&nbsp;EARNINGS PER SHARE (EPS)

Basic EPS is calculated using the weighted average number of common shares outstanding during the period. Diluted EPS is calculated using the weighted average number of common shares outstanding during the period plus shares issuable upon the vesting of performance-based share unit awards and time-vested restricted shares by using the treasury stock method. The number of shares used in the calculation of earnings per share for each period presented is as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months** | **Three Months** | **Nine Months** | **Nine Months** |
|  | **Ended June 30,**  | **Ended June 30,**  | **Ended June 30,**  | **Ended June 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Weighted Average Shares Outstanding — Basic | 25825 | 25753 | 25806 | 25781 |
| Dilutive Shares | 93 | 87 | 70 | 63 |
| Adjusted Shares — Diluted | 25918 | 25840 | 25876 | 25844 |

---

3.&nbsp;&nbsp;&nbsp;&nbsp;ACQUISITION

On April 25, 2025, the Company completed the acquisition of the Signature Management & Power (SM&P) business of Ultra Maritime for a purchase price of approximately $472 million, net of cash acquired. SM&P will become part of ESCO's Aerospace & Defense (A&D) segment and will be known as ESCO Maritime Solutions (Maritime) going forward. Their Signature Management and Power Management product lines are highly complementary to ESCO's current naval programs. Signature Management offers solutions for surface ships and submarines that provide magnetic and electric field countermeasures to prevent underwater mine and sensor detection. Power Management provides innovative and highly-engineered motors that drive critical ship propulsion systems with an ultra-quiet design ensuring low vibration levels to increase stealth capabilities. For the quarter ended June 30, 2025, Maritime had $37.1 million of revenue since the acquisition date. Maritime's revenues for the period from October 1, 2024 through April 25, 2025 (acquisition date) were approximately $103 million with EBIT margins in the mid-twenty percent range, which is comparable to the prior year period.

Since the date of acquisition, the operating results for the Maritime business have been included as part of the A&D segment. The preliminary acquisition date fair value of the assets acquired and liabilities assumed were as follows: $72.2 million of cash, $22.9 million of accounts receivable, $17.0 million of inventory, $15.1 million of contract assets, $1.5 million of prepaid assets, $12.2 million of property, plant and equipment, $5.0 million of other assets, $9.7 million of accounts payable, $14.2 million of accrued expenses and other current liabilities, $104.5 million of contract liabilities, $3.5 million of other liabilities, $46.3 million of deferred tax liabilities, $290.5 million of customer relationships and $61.3 million of backlog. The customer relationships were preliminarily determined to have a useful life of fifteen years and the backlog was determined to have a useful life of two years. Management is still in the process of reviewing the purchase price allocation. The acquired goodwill of $222.7 million relates to the excess value associated with opportunities to expand the services and products that the Company can offer to its customers and access to new markets. The Company does not expect all of the goodwill will be deductible for tax purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

4.&nbsp;&nbsp;&nbsp;&nbsp;ASSETS HELD FOR SALE / DISCONTINUED OPERATIONS

On May 2, 2025, the Board approved and on May 20, 2025, the Company announced it had entered into a definitive agreement to sell VACCO Industries (VACCO) to RBC Bearings Incorporated (RBC), an international manufacturer and marketer of highly engineered precision bearings and products, headquartered in Oxford, Connecticut. Subsequent to June 30, 2025, the Company announced it had completed this divestiture on July 18, 2025. Net proceeds from the transaction were approximately $275 million reflecting customary working capital adjustments attributable to operating activities since the time of the transaction announcement on May 20, 2025. VACCO's assets and liabilities constitute a disposal group to be classified as held for sale and VACCO constitutes a component of the Company with operations and cash flows that are clearly distinguishable, operationally and for financial reporting purposes. Results of operations, financial position and cash flows for the VACCO business are reflected as discontinued operations and/or assets held for sale in the Condensed Consolidated Financial Statements and related notes for all periods presented. The sale of VACCO represents a strategic shift for the Company to exit the Space business.

Net sales from the VACCO business were $30.3 million and $96.4 million for the three and nine-month periods ending June 30, 2025 and $27.2 million and $82.6 million for the respective prior year periods. Pretax earnings from the VACCO business were $1.9 million and $12.1 million for the three and nine-month periods ending June 30, 2025 and $1.2 million and $5.5 million for the respective prior year periods. The net proceeds from the sale of approximately $275 million and the related gain on sale will be recorded in the fourth quarter of 2025.

The major classes of VACCO's assets and liabilities held for sale included in the Condensed Consolidated Balance Sheet at June 30, 2025 and September 30, 2024 are shown below (in thousands).

---

| | | |
|:---|:---|:---|
|  | **June 30,**<br>**2025** | **September 30,**<br>**2024** |
| Assets: |  |  |
| &nbsp;&nbsp;Accounts receivable, net | $10943 | 18579 |
| &nbsp;&nbsp;Contract assets | 50098 | 63822 |
| &nbsp;&nbsp;Inventories | 13346 | 13699 |
| &nbsp;&nbsp;Other current assets | 2165 | 1281 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current assets | 76552 | 97381 |
| Property, plant and equipment, net | 20576 | 21345 |
| Intangible assets, net | 3444 | 4078 |
| Goodwill | 9964 | 9964 |
| Other assets | 804 | 607 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | 111340 | 133375 |
| Liabilities: |  |  |
| Accounts payable | 8150 | 9435 |
| Contract liabilities | 53858 | 44001 |
| Accrued expenses and other current liabilities | 12497 | 9063 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current liabilities | 74505 | 62499 |
| Other liabilities | 2775 | 2710 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $77280 | 65209 |

---

5.&nbsp;&nbsp;&nbsp;&nbsp;SHARE-BASED COMPENSATION

The Company provides compensation benefits to certain key employees under several share-based plans providing for a combination of performance-based share unit (PSU) awards and time-vested restricted share unit (RSU) awards and to non-employee directors under a separate compensation plan.

*Performance Share Unit (PSU) Awards and Time-Vested Restricted Stock Unit (RSU) Awards*

Compensation expense related to these awards was $2.3 million and $6.9 million for the three and nine-month periods ended June 30, 2025, respectively, and $2.0 million and $5.5 million for the corresponding periods in 2024. As of June 30, 2025, there were 213,069 unvested stock units outstanding.

*Non-Employee Directors Plan*

Compensation expense related to the non-employee director grants was $0.4 million and $1.0 million for the three and nine-month periods ended June 30, 2025, respectively, and $0.3 million and $0.9 million for the corresponding periods in 2024.

The total share-based compensation cost that has been recognized in the results of operations and included within selling, general and administrative expenses (SG&A) was $2.6 million and $7.9 million for the three and nine-month periods ended June 30, 2025, respectively, and $2.2 million and $6.4 million for the corresponding periods in 2024. The total income tax benefit recognized in results of operations for share-based compensation arrangements was $0.5 million and $1.6 million for the three and nine-month periods ended June 30, 2025, respectively, and $0.5 million and $1.4 million for the corresponding periods in 2024. As of June 30, 2025, there was $14.3 million of total unrecognized compensation cost related to share-based compensation arrangements. That cost is expected to be recognized over a remaining weighted-average period of 1.6 years.

6.&nbsp;&nbsp;&nbsp;&nbsp;INVENTORIES

Inventories from continuing operations consist of the following:

---

| | | |
|:---|:---|:---|
| <br>**(In thousands)** | **June 30,** <br>**2025** | **September 30,** <br>**2024** |
| Finished goods | $59755 | 46586 |
| Work in process | 55052 | 40605 |
| Raw materials | 122303 | 108274 |
| &nbsp;&nbsp;Total inventories | $237110 | 195465 |

---

&nbsp;&nbsp;&nbsp;&nbsp;7. GOODWILL AND OTHER INTANGIBLE ASSETS

Included on the Company's condensed Consolidated Balance Sheets at June 30, 2025 and September 30, 2024 are the following intangible assets gross carrying amounts and accumulated amortization from continuing operations:

---

| | | |
|:---|:---|:---|
| <br>**(Dollars in thousands)** | **June 30,** <br>**2025** | **September 30,** <br>**2024** |
| Goodwill | $760555 | 529935 |
| Intangible assets with determinable lives: |  |  |
| &nbsp;&nbsp;Patents |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross carrying amount | $7566 | 2638 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: accumulated amortization | 1643 | 1415 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net | $5923 | 1223 |
| &nbsp;&nbsp;Capitalized software |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross carrying amount | $135564 | 126721 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: accumulated amortization | 98058 | 89558 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net | $37506 | 37163 |
| &nbsp;&nbsp;Customer relationships |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross carrying amount | $627932 | 330328 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: accumulated amortization | 149786 | 132135 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net | $478146 | 198193 |
| &nbsp;&nbsp;Other |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross carrying amount | $77441 | 15182 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: accumulated amortization | 16895 | 11173 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net | $60546 | 4009 |
| Intangible assets with indefinite lives: |  |  |
| &nbsp;&nbsp;Trade names | $162958 | 162936 |

---

The changes in the carrying amount of goodwill attributable to each business segment from continuing operations for the nine months ended June 30, 2025 is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(Dollars in millions)** | **USG** | **Test** | **A&D** | **Total** |
| Balance as of September 30, 2024 | $356.9 | 67.4 | 105.6 | 529.9 |
| Acquisition activity  |  |  | 222.7 | 222.7 |
| Foreign currency translation | 3.5 | 0.9 | 3.6 | 8.0 |
| Balance as of June 30, 2025 | $360.4 | 68.3 | 331.9 | 760.6 |

---

8.&nbsp;&nbsp;&nbsp;&nbsp;BUSINESS SEGMENT INFORMATION

The Company is organized based on the products and services that it offers and classifies its business operations in three reportable segments for financial reporting purposes: Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Test and Measurement (Test). The A&D segment's operations consist of PTI Technologies Inc. (PTI), Crissair, Inc. (Crissair), Globe Composite Solutions, LLC (Globe), Mayday Manufacturing Co. (Mayday) and ESCO Maritime Solutions (Maritime). Previously, A&D also included VACCO Industries which is now being reported in discontinued operations. The companies within this segment primarily design and manufacture specialty filtration, fluid control and naval products, including hydraulic filter elements and fluid control devices used in aerospace and defense applications; custom designed filters for manned aircraft and submarines; products and systems to reduce vibration and/or acoustic signatures and otherwise reduce or obscure a vessel's signature, power management and control equipment, sealing, surface control and hydrodynamic related applications to enhance U.S. Navy maritime survivability; precision-tolerance machined components for the aerospace and defense industry; metal processing services; and miniature electro-explosive devices utilized in mission-critical defense and aerospace applications.

The USG segment's operations consist primarily of Doble Engineering Company and related subsidiaries including Morgan Schaffer and Altanova (collectively, Doble), and NRG Systems, Inc. (NRG). Doble is an industry leader in the development, manufacture and delivery of diagnostic testing solutions that enable electric power grid operators to assess the integrity of high voltage power delivery equipment. It combines three core elements for customers – diagnostic test and condition monitoring instruments, expert consulting, and testing services – and provides access to its large reserve of related empirical knowledge. NRG is a global market leader in the design and manufacture of decision support tools for the renewable energy industry, primarily wind and solar.

The Test segment's operations consist primarily of ETS-Lindgren Inc. and related subsidiaries, including MPE Limited (ETS-Lindgren). ETS-Lindgren is an industry leader in designing and manufacturing products and systems to measure and control RF and acoustic energy. It serves the acoustics, medical, health and safety, electronics, wireless communications, automotive and defense markets, supplying a broad range of turnkey systems, including RF test facilities and measurement systems, acoustic test enclosures, RF and magnetically shielded rooms and secure communication facilities, and providing the design, program management, installation and integration services required to successfully complete these types of facilities. It also provides a broad range of components including RF absorptive materials, filters, antennas, field probes, test cells, proprietary measurement software and other test accessories required to perform a variety of tests and measurements, and offers a variety of services including calibration and product tests.

Management evaluates and measures the performance of its reportable segments based on "Net Sales" and "EBIT", which are detailed in the table below. EBIT is defined as earnings before interest and taxes. The table below is presented on the basis of continuing operations and excludes discontinued operations.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months** | **Three Months** | **Nine Months** | **Nine Months** |
| | **Ended June 30,**  | **Ended June 30,**  | **Ended June 30,**  | **Ended June 30,**  |
| <br>**(In thousands)** | **2025** | **2024** | **2025** | **2024** |
| NET SALES |  |  |  |  |
| Aerospace & Defense | $136324 | 87235 | 307819 | 241279 |
| USG | 92357 | 90277 | 269784 | 260570 |
| Test | 67663 | 56056 | 165111 | 143772 |
| Consolidated totals | $296344 | 233568 | 742714 | 645621 |
| EBIT |  |  |  |  |
| Aerospace & Defense | $36577 | 20150 | 78246 | 55919 |
| USG | 21540 | 22155 | 62808 | 57355 |
| Test | 10732 | 9292 | 21523 | 16613 |
| Corporate (loss) | (27859) | (12296) | (56918) | (40289) |
| Consolidated EBIT | 40990 | 39301 | 105659 | 89598 |
| Less: Interest expense | (7921) | (3335) | (12373) | (9228) |
| Earnings before income taxes  | $33069 | 35966 | 93286 | 80370 |

---

*Non-GAAP Financial Measures*

*The financial measure "EBIT" is presented in the above table and elsewhere in this Report. EBIT on a consolidated basis is a non-GAAP financial measure. Management believes that EBIT is useful in assessing the operational profitability of the Company's business segments because it excludes interest and taxes, which are generally accounted for across the entire Company on a consolidated basis. EBIT is also one of the measures used by management in determining resource allocations within the Company as well as incentive compensation. A reconciliation of EBIT to net earnings is set forth in Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations – EBIT.*

The Company believes that the presentation of EBIT provides important supplemental information to investors to facilitate comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results. However, the Company's non-GAAP financial measures may not be comparable to other companies' non-GAAP financial performance measures. Furthermore, the use of non-GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP.

9.&nbsp;&nbsp;&nbsp;&nbsp;DEBT

The Company's debt is summarized as follows:

---

| | | |
|:---|:---|:---|
| <br>**(In thousands)** | **June 30,** <br>**2025** | **September 30,** <br>**2024** |
| Revolving credit facility | 155000 | 122000 |
| Incremental facility (Term loan A) | 370000 |  |
| &nbsp;&nbsp;Total borrowings | $525000 | 122000 |
| &nbsp;&nbsp;Current portion of long-term debt  | (20000) | (20000) |
| &nbsp;&nbsp;Total long-term debt, less current portion | $505000 | 102000 |

---

The Credit Facility includes a $500 million revolving line of credit as well as provisions allowing for the increase of the credit facility commitment amount by an additional $250 million, if necessary, with the consent of the lenders. The bank syndication supporting the facility is comprised of a diverse group of seven banks led by JP Morgan Chase Bank, N.A., as administrative agent, Bank of America, N.A., as syndication agent, and Commerce Bank and TD Bank, N.A. as co-documentation agents. The Credit Facility matures August 30, 2028, with balance due by this date.

On August 5, 2024, the Company and certain of its subsidiaries entered into Amendment No. 1 to the Credit Facility which, among other things, (i) implements a senior incremental delayed draw term loan credit facility in an aggregate principal amount of up to $375 million (the "Incremental Facility"), and (ii) permits the direct or indirect acquisition by the Registrant or certain of its subsidiaries of all the issued and outstanding shares of Ultra PMES Limited, Measurement Systems, Inc., EMS Development

Corporation, and DNE Technologies, Inc. (the "SM&P Acquisition), pursuant to and in accordance with the terms and conditions of that certain Sale and Purchase Agreement, dated July 8, 2024. During the third quarter of 2025, the proceeds of the loans drawn under the Incremental Facility were applied to pay a portion of the cash consideration for the Maritime Acquisition and other customary fees, premiums, expenses and costs incurred in connection with the acquisition. The Incremental Facility matures August 30, 2028, with balance due by this date.

At June 30, 2025, the Company had approximately $338 million available to borrow under the Credit Facility, plus the $250 million increase option subject to the lenders' consent, in addition to $78.7 million cash on hand. The Company classified $20 million as the current portion of long-term debt as of June 30, 2025, as the Company intends to repay this amount as obligated by the repayment terms of the Incremental Facility within the next twelve months. The Company is obligated to repay the Incremental Facility Loan on the last day of each fiscal quarter, commencing on September 30, 2025 (the first full quarter ending after the Funding Date), in an amount equal to (a) 1.25% of the original aggregate principal amount of the Loans for each of the first twelve fiscal quarters ending after the Funding date, and (b) 1.875% of the original aggregate principal amount of the Loans for each fiscal quarter thereafter until the Maturity Date. The letters of credit issued and outstanding under the Credit Facility totaled $7.2 million at June 30, 2025.

Interest on borrowings under the Credit Facility and the Incremental Facility is calculated at a spread ranging from 0.25% to 2.25% over either an Adjusted Term SOFR Rate, Adjusted EURIBOR Rate, Adjusted CDOR Rate, Alternate Base Rate or Daily Simple RFR, at the Company's election. The Credit Facility also requires a facility fee ranging from 12.5 to 25 basis points per annum on the unused portion. The interest rate spreads and the facility fee are subject to increase or decrease depending on the Company's leverage ratio. The weighted average interest rates under the Credit Facility were 6.03% and 5.99% for the three and nine-month periods ending June 30, 2025, respectively, and 6.71% and 6.75% for the three and nine-month periods ending June 30, 2024. The weighted average interest rate under the Incremental Facility was 6.42% for the three-month period ending June 30, 2025. As of June 30, 2025, the Company was in compliance with all covenants.

10. INCOME TAX EXPENSE

The third quarter 2025 effective income tax rate from continuing operations was 25.1% compared to 21.3% in the third quarter of 2024. The effective income tax rate from continuing operations in the first nine months of 2025 was 23.4% compared to 21.2% for the first nine months of 2024. The income tax expense in the third quarter and first nine months of 2025 was unfavorably impacted by income tax consequences associated with the Maritime acquisition, including non - deductible transaction costs and additional income taxed at the UK statutory rate.

On July 4, 2025, President Trump signed H.R. 1, the "One Big Beautiful Bill Act (OBBBA)" into law. The OBBBA extends permanently, with modifications, certain individual, business and international tax provisions enacted as part of the 2017 Tax Cuts and Jobs Act that were set to expire at the end of calendar year 2025, as well as delivers additional tax relief for individuals and businesses. The Company is currently evaluating the impact of the OBBBA on its consolidated financial statements but does not anticipate a material impact to the Company's financial position or results of operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

11. SHAREHOLDERS' EQUITY

The change in shareholders' equity for the first three and nine months of 2025 and 2024 is shown below (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended June 30,**  | **Three Months Ended June 30,**  | **Nine Months Ended June 30,**  | **Nine Months Ended June 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Common stock |  |  |  |  |
| &nbsp;&nbsp;Beginning balance | 309 | 308 | 308 | 308 |
| &nbsp;&nbsp;Stock plans |  |  | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ending balance | 309 | 308 | 309 | 308 |
| Additional paid-in-capital |  |  |  |  |
| &nbsp;&nbsp;Beginning balance | 311438 | 308065 | 311942 | 304850 |
| &nbsp;&nbsp;Stock plans | 2211 | 1917 | 1707 | 5132 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ending balance | 313649 | 309982 | 313649 | 309982 |
| Retained earnings |  |  |  |  |
| &nbsp;&nbsp;Beginning balance | 1133326 | 1023578 | 1082950 | 989315 |
| &nbsp;&nbsp;Net earnings common stockholders | 26065 | 29230 | 80571 | 67618 |
| &nbsp;&nbsp;Dividends paid | (2066) | (2060) | (6196) | (6185) |
| &nbsp;&nbsp;&nbsp;&nbsp;Ending balance | 1157325 | 1050748 | 1157325 | 1050748 |
| Accumulated other comprehensive income (loss) |  |  |  |  |
| &nbsp;&nbsp;Beginning balance | (20670) | (19300) | (10775) | (23969) |
| &nbsp;&nbsp;Foreign currency translation | 23076 | (1001) | 13181 | 3668 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ending balance | 2406 | (20301) | 2406 | (20301) |
| Treasury stock |  |  |  |  |
| &nbsp;&nbsp;Beginning balance | (147075) | (146241) | (147075) | (139362) |
| &nbsp;&nbsp;Share repurchases |  | (810) |  | (7689) |
| &nbsp;&nbsp;&nbsp;&nbsp;Ending balance | (147075) | (147051) | (147075) | (147051) |
| Total equity | 1326614 | 1193686 | 1326614 | 1193686 |

---

12. FAIR VALUE MEASUREMENTS

The accounting guidance establishes a three-level hierarchy for disclosure of fair value measurements, based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date, as follows:

● Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

● Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

● Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.

*Financial Assets and Liabilities*

The Company has estimated the fair value of its financial instruments as of June 30, 2025 and September 30, 2024 using available market information or other appropriate valuation methodologies. The carrying amounts of cash and cash equivalents, receivables, inventories, payables, and other current assets and liabilities approximate fair value because of the short maturity of those instruments.

*Fair Value of Financial Instruments*

The Company's forward contracts and interest rate swaps are classified within Level 2 of the valuation hierarchy in accordance with FASB Accounting Standards Codification (ASC) 825, and are immaterial.

*Nonfinancial Assets and Liabilities*

The Company's nonfinancial assets such as property, plant and equipment, and other intangible assets are not measured at fair value on a recurring basis; however, they are subject to fair value adjustments in certain circumstances, such as when there is evidence that an impairment may exist. No impairments were recorded during the three and nine-month periods ended June 30, 2025.

13. REVENUES

*Disaggregation of Revenues*

Revenues by customer type, geographic location, and revenue recognition method for the three and nine-month periods ended June 30, 2025 are presented in the tables below as the Company deems it best depicts how the nature, amount, timing and uncertainty of net sales and cash flows are affected by economic factors. The tables below also include a reconciliation of the disaggregated revenue from continuing operations within each reportable segment.

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Three months ended June 30, 2025*** | | | | |
| ***(In thousands)*** | <br>**A&D** | <br>**USG** | <br>**Test** | <br>**Total** |
| &nbsp;&nbsp;**Customer type:** |  |  |  |  |
| Commercial | $57297 | $87653 | $50591 | $195541 |
| Government | 79027 | 4704 | 17072 | 100803 |
| &nbsp;&nbsp;Total revenues | $136324 | $92357 | $67663 | $296344 |
| &nbsp;&nbsp;**Geographic location:** |  |  |  |  |
| United States | $94518 | $63062 | $36188 | $193768 |
| International | 41806 | 29295 | 31475 | 102576 |
| &nbsp;&nbsp;Total revenues | $136324 | $92357 | $67663 | $296344 |
| &nbsp;&nbsp;**Revenue recognition method:** |  |  |  |  |
| Point in time | $66833 | $74143 | $11123 | $152099 |
| Over time | 69491 | 18214 | 56540 | 144245 |
| &nbsp;&nbsp;Total revenues | $136324 | $92357 | $67663 | $296344 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Nine months ended June 30, 2025*** | | | | |
| ***(In thousands)*** | <br>**A&D** | <br>**USG** | <br>**Test** | <br>**Total** |
| &nbsp;&nbsp;**Customer type:** |  |  |  |  |
| Commercial | $151756 | $261581 | $124831 | $538168 |
| Government | 156063 | 8203 | 40280 | 204546 |
| &nbsp;&nbsp;Total revenues | $307819 | $269784 | $165111 | $742714 |
| &nbsp;&nbsp;**Geographic location:** |  |  |  |  |
| United States | $226444 | $173121 | $97086 | $496651 |
| International | 81375 | 96663 | 68025 | 246063 |
| &nbsp;&nbsp;Total revenues | $307819 | $269784 | $165111 | $742714 |
| &nbsp;&nbsp;**Revenue recognition method:** |  |  |  |  |
| Point in time | $166191 | $216423 | $32522 | $415136 |
| Over time | 141628 | 53361 | 132589 | 327578 |
| &nbsp;&nbsp;Total revenues | $307819 | $269784 | $165111 | $742714 |

---

Revenues by customer type, geographic location, and revenue recognition method for the three and nine-month periods ended June 30, 2024 are presented in the tables below.

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Three months ended June 30, 2024*** | | | | |
| ***(In thousands)*** | <br>**A&D** | <br>**USG** | <br>**Test** | <br>**Total** |
| &nbsp;&nbsp;**Customer type:** |  |  |  |  |
| Commercial | $43927 | $88076 | $42327 | $174330 |
| Government | 43308 | 2201 | 13729 | 59238 |
| &nbsp;&nbsp;Total revenues | $87235 | $90277 | $56056 | $233568 |
| &nbsp;&nbsp;**Geographic location:** |  |  |  |  |
| United States | $69228 | $54063 | $32575 | $155866 |
| International | 18007 | 36214 | 23481 | 77702 |
| &nbsp;&nbsp;Total revenues | $87235 | $90277 | $56056 | $233568 |
| &nbsp;&nbsp;**Revenue recognition method:** |  |  |  |  |
| Point in time | $51234 | $72985 | $11426 | $135645 |
| Over time | 36001 | 17292 | 44630 | 97923 |
| &nbsp;&nbsp;Total revenues | $87235 | $90277 | $56056 | $233568 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Nine months ended June 30, 2024*** | | | | |
| ***(In thousands)*** | <br>**A&D** | <br>**USG** | <br>**Test** | <br>**Total** |
| &nbsp;&nbsp;**Customer type:** |  |  |  |  |
| Commercial | $126191 | $254765 | $111951 | $492907 |
| Government | 115088 | 5805 | 31821 | 152714 |
| &nbsp;&nbsp;Total revenues | $241279 | $260570 | $143772 | $645621 |
| &nbsp;&nbsp;**Geographic location:** |  |  |  |  |
| United States | $190264 | $165789 | $82370 | $438423 |
| International | 51015 | 94781 | 61402 | 207198 |
| &nbsp;&nbsp;Total revenues | $241279 | $260570 | $143772 | $645621 |
| &nbsp;&nbsp;**Revenue recognition method:** |  |  |  |  |
| Point in time | $137769 | $209973 | $29706 | $377448 |
| Over time | 103510 | 50597 | 114066 | 268173 |
| &nbsp;&nbsp;Total revenues | $241279 | $260570 | $143772 | $645621 |

---

*Revenue Recognition*

Payment terms with our customers vary by the type and location of the customer and the products or services offered. Arrangements with customers that include payment terms extending beyond one year are not significant. The transaction price for these contracts reflects our estimate of returns and discounts, which are based on historical, current and forecasted information to determine the expected amount to which we will be entitled in exchange for transferring the promised goods or services to the customer. The realization of variable consideration occurs within a short period of time from product delivery; therefore, the time value of money effect is not significant. We primarily provide standard warranty programs for products in our commercial businesses for periods that typically range from one to two years. These assurance-type programs typically cannot be purchased separately and do not meet the criteria to be considered a performance obligation. Under the typical payment terms of our long term fixed price contracts, the customer pays us either performance-based or progress payments. Performance-based payments represent interim payments based on quantifiable measures of performance or on the achievement of specified events or milestones. Progress payments are interim payments of costs incurred as the work progresses.

For our overtime revenue recognized using the output method of costs incurred, contract cost is estimated utilizing current contract specifications and expected engineering requirements. Contract costs typically are incurred over a period of several months to one or more years, and the estimation of these costs requires judgment. Our cost estimation process is based on the professional knowledge and experience of engineers and program managers along with finance professionals. We review and update our projections of costs quarterly or more frequently when circumstances significantly change. In addition, in the USG segment, we recognize revenue as a series of distinct services based on each day of providing services (straight-line over the contract term) for certain of our USG segment contracts. Under the typical payment terms of our service contracts, the customer pays us in advance of when services are performed. In addition, in the Test segment, we use milestones to measure progress for our Test segment contracts because it best depicts the transfer of control to the customer that occurs as we incur costs on our contracts.

*Remaining Performance Obligations*

Remaining performance obligations, which is the equivalent of backlog, represent the expected transaction price allocated to contracts that the Company expects to recognize as revenue in future periods when the Company performs under the contracts. These remaining obligations include amounts that have been formally appropriated under contracts with the U.S. Government, and exclude unexercised contract options and potential orders under ordering-type contracts such as Indefinite Delivery, Indefinite Quantity contracts. At June 30, 2025, the Company had $1,165.4 million in remaining performance obligations of which the Company expects to recognize revenues of approximately 66% in the next twelve months.

*Contract assets, contract liabilities and accounts receivable*

Assets and liabilities related to contracts with customers are reported on a contract-by-contract basis at the end of each reporting period. At June 30, 2025, contract assets, contract liabilities and accounts receivable from continuing operations totaled $91.7 million, $214.1 million and $238.0 million, respectively. During the first nine months of 2025, the Company recognized approximately $54 million in revenues that were included in the contract liabilities balance at September 30, 2024. At September 30, 2024, contract assets, contract liabilities and accounts receivable from continuing operations totaled $66.7 million, $90.3 million and $222.1 million, respectively.

14. LEASES

The Company determines at lease inception whether an arrangement that provides control over the use of an asset is a lease. The Company recognizes at lease commencement a right-of-use (ROU) asset and lease liability based on the present value of the future lease payments over the lease term. The Company has elected not to recognize a ROU asset and lease liability for leases with terms of 12 months or less. Certain of the Company's leases include options to extend the term of the lease for up to 20 years. When it is reasonably certain that the Company will exercise the option, Management includes the impact of the option in the lease term for purposes of determining total future lease payments. As most of the Company's lease agreements do not explicitly state the discount rate implicit in the lease, Management uses the Company's incremental borrowing rate on the commencement date to calculate the present value of future payments based on the tenor of each arrangement.

The Company's leases for real estate commonly include escalating payments. These variable lease payments are included in the calculation of the ROU asset and lease liability. In addition to the present value of the future lease payments, the calculation of the ROU asset also includes any deferred rent, lease pre-payments and initial direct costs of obtaining the lease.

In addition to the base rent, real estate leases typically contain provisions for common-area maintenance and other similar services, which are considered non-lease components for accounting purposes. Non-lease components are excluded from our ROU assets and lease liabilities and expensed as incurred.

The Company's leases are for office space, manufacturing facilities, and machinery and equipment.

The components of lease costs are shown below:

---

| | | |
|:---|:---|:---|
| <br>**(Dollars in thousands)** | **Three Months Ended** <br>**June 30,** <br>**2025** | **Three Months Ended** <br>**June 30,** <br>**2024** |
| Finance lease cost |  |  |
| &nbsp;&nbsp;Amortization of right-of-use assets | $372 | $372 |
| &nbsp;&nbsp;Interest on lease liabilities | 199 | 213 |
| Operating lease cost | 2067 | 1676 |
| Total lease costs | $2638 | $2261 |

---

---

| | | |
|:---|:---|:---|
| <br>**(Dollars in thousands)** | **Nine Months Ended** <br>**June 30,** <br>**2025** | **Nine Months Ended** <br>**June 30,** <br>**2024** |
| Finance lease cost |  |  |
| &nbsp;&nbsp;Amortization of right-of-use assets | $1116 | $1137 |
| &nbsp;&nbsp;Interest on lease liabilities | 607 | 652 |
| Operating lease cost | 5528 | 4892 |
| Total lease costs | $7251 | $6681 |

---

Additional information related to leases are shown below:

---

| | | |
|:---|:---|:---|
| <br>**(Dollars in thousands)** | **Three Months Ended** <br>**June 30,** <br>**2025** | **Three Months Ended** <br>**June 30,** <br>**2024** |
| Cash paid for amounts included in the measurement of lease liabilities |  |  |
| &nbsp;&nbsp;Operating cash flows from operating leases | $1958 | $1605 |
| &nbsp;&nbsp;Operating cash flows from finance leases | 199 | 213 |
| &nbsp;&nbsp;Financing cash flows from finance leases | 358 | 331 |
| Right-of-use assets obtained in exchange for operating lease liabilities | 10259 | 515 |

---

---

| | | |
|:---|:---|:---|
| <br>**(Dollars in thousands)** | **Nine Months Ended** <br>**June 30,** <br>**2025** | **Nine Months Ended** <br>**June 30,** <br>**2024** |
| Cash paid for amounts included in the measurement of lease liabilities |  |  |
| &nbsp;&nbsp;Operating cash flows from operating leases | $5271 | $4724 |
| &nbsp;&nbsp;Operating cash flows from finance leases | 607 | 652 |
| &nbsp;&nbsp;Financing cash flows from finance leases | 1065 | 1013 |
| Right-of-use assets obtained in exchange for operating lease liabilities | 14232 | 2194 |

---

---

| | | |
|:---|:---|:---|
|  | **June 30,** <br>**2025** | **June 30,** <br>**2024** |
| Weighted-average remaining lease term |  |  |
| &nbsp;&nbsp;Operating leases | 9.6<br> years | 10.8<br> years |
| &nbsp;&nbsp;Finance leases | 9.8<br> years | 11.1<br> years |
| Weighted-average discount rate |  |  |
| &nbsp;&nbsp;Operating leases | 4.75% | 4.58% |
| &nbsp;&nbsp;Finance leases | 4.73% | 4.69% |

---

The following is a reconciliation of future undiscounted cash flows to the operating and finance lease liabilities, and the related ROU assets, presented on our condensed Consolidated Balance Sheet on June 30, 2025:

---

| | | |
|:---|:---|:---|
| **(Dollars in thousands)**<br>**Years Ending September 30:** | **Operating**<br>**Leases** | **Finance**<br>**Leases** |
| 2025 (excluding the nine months ended June 30, 2025) | $2007 | 561 |
| 2026 | 7470 | 2297 |
| 2027 | 7225 | 2357 |
| 2028 | 7095 | 2417 |
| 2029 and thereafter | 38434 | 14053 |
| &nbsp;&nbsp;Total minimum lease payments | 62231 | 21685 |
| &nbsp;&nbsp;Less: amounts representing interest | 12977 | 4766 |
| &nbsp;&nbsp;Present value of net minimum lease payments | $49254 | 16919 |
| &nbsp;&nbsp;Less: current portion of lease obligations | 5621 | 1523 |
| &nbsp;&nbsp;Non-current portion of lease obligations | 43633 | 15396 |
| &nbsp;&nbsp;ROU assets | $46796 | 12566 |

---

Operating lease liabilities are included in the condensed Consolidated Balance Sheet in accrued other expenses (current portion) and as a caption on the Consolidated Balance Sheet (long-term portion). Finance lease liabilities are included on the Consolidated Balance Sheet in accrued other expenses (current portion) and other liabilities (long-term portion). Operating lease ROU assets are included as a caption on the Consolidated Balance Sheet and finance lease ROU assets are included in Property, plant and equipment on the Consolidated Balance sheet.

15. NEW ACCOUNTING PRONOUNCEMENTS

In November 2024, the FASB issued ASU 2024-03, "*Disaggregation of Income Statement Expenses*," which requires disaggregated disclosure of income statement expenses for public business entities. The ASU does not change the expense captions an entity presents on the face of the income statement, rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. This ASU will be effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Other than additional disclosure, we do not expect a change to our consolidated statements of operations, financial position, or cash flows.

In December 2023, the FASB issued ASU 2023-09, "*Income Taxes (Topic 740): Improvements to Income Tax Disclosures*," which provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures. This ASU will be effective for fiscal years beginning after December 15, 2024. Other than additional disclosure, we do not expect a change to our consolidated statements of operations, financial position, or cash flows.

In November 2023, the FASB issued ASU 2023-07, "*Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,*" which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant expenses. The new segment disclosures are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Other than additional disclosure, we do not expect a change to our consolidated statements of operations, financial position, or cash flows.

16. SUBSEQUENT EVENT

See subsequent event item noted in footnote 4 related to the Company's divestiture of VACCO.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

The following discussion refers to the Company's results from continuing operations, except where noted. In the third quarter of 2025, the Company announced it had entered into a definitive agreement to sell VACCO Industries (VACCO) to RBC Bearings Incorporated. This transaction was completed subsequent to June 30, 2025, on July 18, 2025. VACCO is reflected as discontinued operations and/or assets held for sale in the financial statements and related notes for all periods shown. References to the third quarters of 2025 and 2024 represent the three-month periods ended June 30, 2025 and 2024, respectively.

OVERVIEW

In the third quarter of 2025, sales, net earnings and diluted earnings per share from continuing operations were $296.3 million, $24.8 million and $0.96 per share, respectively, compared to $233.6 million, $28.3 million and $1.10 per share, respectively, in the third quarter of 2024. In the first nine months of 2025, sales, net earnings and diluted earnings per share were $742.7 million, $71.4 million and $2.76 per share, respectively, compared to $645.6 million, $63.3 million and $2.46 per share, respectively, in the first nine months of 2024.

NET SALES

In the third quarter of 2025, net sales of $296.3 million were $62.7 million, or 26.8%, higher than the $233.6 million in the third quarter of 2024. In the first nine months of 2025, net sales of $742.7 million were $97.1 million, or 15.0%, higher than the $645.6 million in the first nine months of 2024. The increase in net sales in the third quarter of 2025 as compared to the third quarter of 2024 was due to a $49.0 million increase in the A&D segment, a $11.6 million increase in the Test segment and a $2.1 million increase in the USG segment. The increase in net sales in the first nine months of 2025 as compared to the first nine months of 2024 was due to a $66.5 million increase in the A&D segment, a $21.4 million increase in the Test segment and a $9.2 million increase in the USG segment.

-*A&D*

In the third quarter of 2025, net sales of $136.3 million were $49.1 million, or 56.3%, higher than the $87.2 million in the third quarter of 2024. In the first nine months of 2025, net sales of $307.8 million were $66.5 million, or 27.6%, higher than the $241.3 million in the first nine months of 2024. The sales increase in the third quarter of 2025 compared to the third quarter of 2024 was mainly due to a $34.3 million increase in navy revenues, and a $13.0 million increase in commercial and defense aerospace shipments. Organic sales (excluding $37.1 million of Maritime revenue for the two months post-closing) increased $12.0 million to $99.2 million. The sales increase in the first nine months of 2025 compared to the first nine months of 2024 was mainly due to a $37.4 million increase in navy revenues, a $30.6 million increase in commercial aerospace shipments, and a $2.2 million increase in industrial shipments partially offset by a $3.9 million decrease in defense aerospace shipments.

-*USG*

In the third quarter of 2025, net sales of $92.4 million were $2.1 million, or 2.3%, higher than the $90.3 million in the third quarter of 2024. In the first nine months of 2025, net sales of $269.8 million were $9.2 million, or 3.5%, higher than the $260.6 million in the first nine months of 2024. The increase in the third quarter of 2025 compared to the third quarter of 2024 was mainly due to an increase in net sales of NRG's wind and solar products and an increase in net sales at Doble driven by higher offline test products. The increase in the first nine months of 2025 compared to the corresponding period of 2024 was mainly due to an increase in net sales at Doble driven by higher sales of offline products and services partially offset by lower NRG sales due to renewables market weakness.

*-Test*

In the third quarter of 2025, net sales of $67.7 million were $11.6 million, or 20.7%, higher than the $56.1 million in the third quarter of 2024. In the first nine months of 2025, net sales of $165.1 million were $21.3 million, or 14.8%, higher than the $143.8 million in the first nine months of 2024. The increase in the third quarter of 2025 as compared to the third quarter of 2024 was primarily due to a $6.9 million increase in sales from the segment's U.S. and European operations and a $4.7 million increase in sales from the segment's Asian operations due to higher Test and Measurement, industrial shielding, medical services, and filters volumes. The increase in the first nine months of 2025 compared to the first nine months of 2024 was due to a $18.9 million increase in sales from the segment's U.S. and European operations and a $2.4 million increase in sales from the segment's Asian operations for reasons mentioned above.

ORDERS AND BACKLOG

Backlog from continuing operations was $1,165 million at June 30, 2025 compared with $664 million at September 30, 2024. The Company received new orders totaling $749.1 million in the third quarter of 2025 compared to $254.9 million in the third quarter of 2024. Of the new orders received in the third quarter of 2025, $582.4 million related to A&D products (including $364.2 million of Maritime acquired backlog), $105.5 million related to USG products, and $61.2 million related to Test products. Of the new orders received in the third quarter of 2024, $90.1 million related to A&D products, $100.0 million related to USG products, and $64.8 million related to Test products.

The Company received new orders totaling $1,243.9 million in the first nine months of 2025 compared to $752.3 million in the first nine months of 2024. Of the new orders received in the first nine months of 2025, $753.7 million related to A&D products (including $364.2 million of Maritime acquired backlog), $287.3 million related to USG products, and $202.9 million related to Test products. Of the new orders received in the first nine months of 2024, $342.3 million related to A&D products, $256.0 million related to USG products, and $154.0 million related to Test products.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative (SG&A) expenses from continuing operations for the third quarter of 2025 were $62.0 million (20.9% of net sales), compared with $51.0 million (21.8% of net sales) for the third quarter of 2024. For the first nine months of 2025, SG&A expenses were $171.3 million (23.1% of net sales) compared to $152.6 million (23.6% of net sales) for the first nine months of 2024. The increase in SG&A in the third quarter and first nine months of 2025 compared to the corresponding periods of 2024 was due to an increase within the A&D segment due to the Maritime acquisition, increased expenses at all three business segments primarily related to higher sales and inflationary impacts and an increase at Corporate mainly due to acquisition costs.

AMORTIZATION OF INTANGIBLE ASSETS

Amortization of intangible assets was $16.8 million and $32.7 million for the third quarter and first nine months of 2025, respectively, compared to $8.1 million and $24.6 million for the corresponding periods of 2024. Amortization expenses consist of amortization of acquired intangible assets from acquisitions and other identifiable intangible assets (primarily software). The increase in amortization expense in the third quarter and first nine months of 2025 compared to the corresponding periods of 2024 was mainly due to an increase in amortization of intangible assets related to the Maritime acquisition.

OTHER EXPENSES (INCOME), NET

Other expenses, net, was $2.2 million in the third quarter of 2025 compared to other (income) of ($0.3) million in the third quarter of 2024. Other expenses, net, was $1.9 million in the first nine months of 2025 compared to $0.4 million of expenses in the first nine months of 2024. The principal component of other expenses, net, in the third quarter and first nine months of 2025 was $1.3 million of UK stamp duties on the Maritime acquisition. There were no individually significant items in other expenses (income), net, in the third quarter of 2024. The principal component of other expenses, net, in the first nine months of 2024 was approximately $0.5 million of restructuring charges (primarily severance) within the Test, USG and A&D segments.

EBIT

The Company evaluates the performance of its operating segments based on EBIT, and provides EBIT on a consolidated basis. EBIT is a non-GAAP financial measure. Please refer to the discussion of non-GAAP financial measures in Note 8 to the condensed Consolidated Financial Statements, above. EBIT from continuing operations was $41.0 million (13.8% of net sales) for the third quarter of 2025 compared to $39.3 million (16.8% of net sales) for the third quarter of 2024. For the first nine months of 2025, EBIT was $105.7 million (14.2% of net sales) compared to $89.6 million (13.9% of net sales) for the first nine months of 2024.

The following table presents a reconciliation of EBIT from continuing operations to net earnings.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended**  | **Three Months Ended**  | **Nine Months Ended**  | **Nine Months Ended**  |
| | **June 30,**  | **June 30,**  | **June 30,**  | **June 30,**  |
| <br>**(In thousands)** | **2025** | **2024** | **2025** | **2024** |
| Net earnings | $24755 | 28312 | 71445 | 63330 |
| Plus: Interest expense, net | 7921 | 3335 | 12373 | 9228 |
| Plus: Income tax expense | 8314 | 7654 | 21841 | 17040 |
| Consolidated EBIT from continuing operations | $40990 | 39301 | 105659 | 89598 |

---

-*A&D*

EBIT in the third quarter of 2025 was $36.6 million (26.8% of net sales) compared to $20.2 million (23.1% of net sales) in the third quarter of 2024. EBIT in the first nine months of 2025 was $78.2 million (25.4% of net sales) compared to $55.9 million (23.2% of net sales) in the first nine months of 2024. The increase in EBIT in the third quarter and first nine months of 2025 compared to the corresponding periods of 2024 was mainly driven by leverage on higher sales volumes including the Maritime acquisition, price increases and mix, partially offset by inflationary pressures. EBIT in the third quarter and first nine months of 2025 was negatively impacted by $2.7 million of inventory step-up charges and stamp duty charges related to the Maritime acquisition.

-*USG*

EBIT in the third quarter of 2025 was $21.5 million (23.3% of net sales) compared to $22.2 million (24.5% of net sales) in the third quarter of 2024. EBIT in the first nine months of 2025 was $62.8 million (23.3% of net sales) compared to $57.4 million (22.0% of net sales) in the first nine months of 2024. The decrease in EBIT in the third quarter of 2025 compared to the third quarter of 2024 was due to unfavorable mix at Doble and inflationary pressures, partially offset by price increases. The increase in EBIT in the first nine months of 2025 compared to the corresponding periods of 2024 was mainly due to leverage on higher sales volumes at Doble and price increases, partially offset by inflationary pressures. EBIT was negatively impacted by $0.3 million of restructuring charges (primarily severance) in the first nine months of 2025.

-*Test*

EBIT in the third quarter of 2025 was $10.7 million (15.9% of net sales) compared to $9.3 million (16.6% of net sales) in the third quarter of 2024. EBIT in the first nine months of 2025 was $21.5 million (13.0% of net sales) compared to $16.6 million (11.6% of net sales) in the first nine months of 2024. The increase in EBIT in the third quarter and first nine months of 2025 compared to the corresponding periods of 2024 was primarily due to higher sales volumes, price increases and cost reduction actions partially offset by inflationary pressures. In addition, EBIT was negatively impacted by $0.4 million in the first nine months of 2025 by restructuring charges (primarily severance). EBIT was negatively impacted by $0.3 million of inventory step-up charges related to the MPE acquisition and $0.2 million of restructuring charges in the first nine months of 2024.

–*Corporate*

Corporate costs included in EBIT were $27.9 million and $56.9 million in the third quarter and first nine months of 2025, respectively, compared to $12.3 million and $40.3 million in the corresponding periods of 2024. The increase in Corporate costs in the third quarter and first nine months of 2025 as compared to the corresponding periods of 2024 was mainly due to an $8.4 million increase in acquisition related amortization and $5.2 million of acquisition costs, both due to the Maritime acquisition, as well as an increase in share-based compensation costs.

INTEREST EXPENSE, NET

Interest expense was $7.9 million and $12.4 million in the third quarter and first nine months of 2025, respectively, and $3.3 million and $9.2 million in the corresponding periods of 2024. The increase in interest expense in the third quarter and first nine months of 2025 compared to the corresponding periods of 2024 was mainly due to higher average outstanding borrowings due to the Maritime acquisition in April 2025. The weighted average outstanding borrowings were $599 million and $274 million for the three and nine-month periods ending June 30, 2025 and $184 million and $173 million for the three and nine-month periods ending June 30, 2024.

INCOME TAX EXPENSE

The third quarter 2025 effective income tax rate from continuing operations was 25.1% compared to 21.3% in the third quarter of 2024. The effective income tax rate from continuing operations in the first nine months of 2025 was 23.4% compared to 21.2% for the first nine months of 2024. The income tax expense in the third quarter and first nine months of 2025 was unfavorably impacted by income tax consequences associated with the Maritime acquisition, including non-deductible transaction costs and additional income taxed at the UK statutory rate.

CAPITAL RESOURCES AND LIQUIDITY

The Company's overall financial position and liquidity remains strong. Working capital from continuing operations (current assets less current liabilities) decreased to $255.8 million at June 30, 2025 from $283.9 million at September 30, 2024. The main driver of the decrease was an increase in contract liabilities of $124.7 million primarily due to the Maritime acquisition and an increase within the USG segment. Inventories increased $41.6 million during this period due to a $25.4 million increase within the A&D segment primarily due to the Maritime acquisition, and a $11.5 million increase within the USG segment and a $4.7 million increase within the Test segment primarily from an increase in finished goods and raw materials inventories due to timing of manufacturing existing orders.

Net cash provided by operating activities from continuing operations was $88.3 million and $63.1 million in the first nine months of 2025 and 2024, respectively. The increase in net cash provided by operating activities in the first nine months of 2025 as compared to the first nine months of 2024 was mainly driven by lower working capital and higher earnings.

Capital expenditures for continuing operations were $24.2 million and $19.6 million in the first nine months of 2025 and 2024, respectively. In addition, the Company incurred expenditures for capitalized software and other intangible assets from continuing operations of $13.0 million and $8.5 million in the first nine months of 2025 and 2024, respectively.

*Credit Facility*

At June 30, 2025, the Company had approximately $338 million available to borrow under its bank credit facility, a $250 million increase option, and $78.7 million cash on hand. At June 30, 2025, the Company had $505 million of outstanding borrowings under the Credit Facility and Incremental Facility in addition to outstanding letters of credit of $7.2 million. Cash flow from operations and borrowings under the Company's credit facility are expected to meet the Company's capital requirements and operational needs for the foreseeable future. The Company's ability to access the additional $250 million increase option of the credit facility is subject to acceptance by participating or other outside banks.

*Acquisition*

On April 25, 2025, the Company completed the acquisition of the Signature Management & Power (SM&P) business of Ultra Maritime for a purchase price of approximately $472 million, net of cash acquired. SM&P will become part of ESCO's Aerospace & Defense (A&D) segment and will be known as ESCO Maritime Solutions (Maritime) going forward. Their Signature Management and Power Management product lines are highly complementary to ESCO's current naval programs. Signature Management offers solutions for surface ships and submarines that provide magnetic and electric field countermeasures to prevent underwater mine and sensor detection. Power Management provides innovative and highly-engineered motors that drive critical ship propulsion systems with an ultra-quiet design ensuring low vibration levels to increase stealth capabilities. Since the date of acquisition, the operating results for the Maritime business have been included as part of the A&D segment.

*Divestiture*

On May 20, 2025, the Company announced it had entered into a definitive agreement to sell VACCO Industries (VACCO) to RBC Bearings Incorporated (RBC), an international manufacturer and marketer of highly engineered precision bearings and products, headquartered in Oxford, Connecticut. Subsequent to June 30, 2025, the Company announced it had completed this divestiture on July 18, 2025. Net proceeds from the transaction were approximately $275 million reflecting customary working capital adjustments attributable to operating activities since the time of the transaction announcement on May 20, 2025.

*Dividends*

A dividend of $0.08 per share, totaling $2.1 million, was paid on October 16, 2024 to stockholders of record as of October 2, 2024. A dividend of $0.08 per share, totaling $2.1 million, was paid on January 17, 2025 to stockholders of record as of January 2, 2025. A dividend of $0.08 per share, totaling $2.1 million, was paid on April 17, 2025 to stockholders of record as of April 2, 2025. Subsequent to June 30, 2025, a quarterly dividend of $0.08 per share, totaling $2.1 million, was paid on July 17, 2025 to stockholders of record as of July 12, 2025.

CRITICAL ACCOUNTING POLICIES

Management has evaluated the accounting policies used in the preparation of the Company's financial statements and related notes and believes those policies to be reasonable and appropriate. Certain of these accounting policies require the application of significant judgment by Management in selecting appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on historical experience, trends in the industry, information provided by customers and information available from other outside sources, as appropriate. The most significant areas involving Management judgments and estimates may be found in the Critical Accounting Policies section of Management's Discussion and Analysis and in Note 1 to the condensed Consolidated Financial Statements contained in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2024.

OTHER MATTERS

*Contingencies*

As a normal incident of the business in which the Company is engaged, various claims, charges and litigation are asserted or commenced against the Company. Additionally, the Company is currently involved in various stages of investigation and remediation relating to environmental matters. In the opinion of Management, the aggregate costs involved in the resolution of these matters, and final judgments, if any, which might be rendered against the Company, are adequately reserved, are covered by insurance, or would not have a material adverse effect on the Company's results from operations, capital expenditures, or competitive position.

FORWARD LOOKING STATEMENTS

Statements contained in this Form 10-Q regarding future events and the Company's future results that reflect or are based on current expectations, estimates, forecasts, projections or assumptions about the Company's performance and the industries in which the Company operates are considered "forward-looking statements" within the meaning of the safe harbor provisions of the Federal securities laws. These may include, but are not necessarily limited to, statements about: the strength of certain end markets served by the Company, and the timing of the recovery of certain end markets which the Company serves; the adequacy of the Company's credit facility and the Company's ability to increase it; the outcome of current litigation, claims and charges; the determination of the current portion of the Company's long-term debt and the timing of its repayment; future revenues from remaining performance obligations; fair values of reporting units; the deductibility of goodwill; estimates and assumptions that affect the reported values of assets and liabilities; the future recognition of compensation cost related to share-based compensation arrangements; the Company's ability to hedge against or otherwise manage market risks through the use of derivative financial instruments; the extent to which hedging gains or losses will be offset by losses or gains on related underlying exposures; and any other statements contained herein which are not strictly historical. Words such as expects, anticipates, targets, goals, projects, intends, plans, believes, estimates, variations of such words, and similar expressions are intended to identify such forward-looking statements.

Investors are cautioned that such statements are only predictions and speak only as of the date of this Form 10-Q, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company's actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company's operations and business environment, including but not limited to those described in Item 1A, "Risk Factors," of the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2024, and the following: the impacts of climate change and related regulation of greenhouse gases; the impacts of labor disputes, civil disorder, wars, elections, political changes, tariffs and trade disputes, terrorist activities, cyberattacks or natural disasters on the Company's operations and those of the Company's customers and suppliers; disruptions in manufacturing or delivery arrangements due to shortages or unavailability of materials or components; or supply chain disruptions; inability to access work sites; the timing and content of future contract awards or customer orders; the timely appropriation, allocation and availability of Government funds; the termination for convenience of Government and other customer contracts or orders; weakening of economic conditions in served markets; the success of the Company's competitors; changes in customer demands or customer insolvencies; competition; intellectual property rights; technical difficulties or data breaches; the availability of selected acquisitions; delivery delays or defaults by customers; performance issues with key customers, suppliers and subcontractors; material changes in the costs and availability of certain raw materials; material changes in the cost of credit; changes in laws and regulations including but not limited to changes in accounting standards and taxation; changes in interest, inflation and employment rates; costs relating to environmental matters arising from current or former facilities; uncertainty regarding the ultimate resolution of current disputes, claims, litigation or arbitration; and the integration and performance of recently acquired businesses.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risks relating to the Company's operations result primarily from changes in interest rates and changes in foreign currency exchange rates. The Company is exposed to market risk related to changes in interest rates and selectively uses derivative financial instruments, including forward contracts and swaps, to manage these risks. The Company's Canadian subsidiary Morgan Schaffer enters into foreign exchange contracts to manage foreign currency risk as a portion of their revenue is denominated in U.S. dollars. All derivative instruments are reported on the balance sheet at fair value. For derivative instruments designated as cash flow hedges, the gain or loss on the respective derivative is deferred in accumulated other comprehensive income until recognized in earnings with the underlying hedged item. There has been no material change to the Company's market risks since September 30, 2024.

ITEM 4. CONTROLS AND PROCEDURES

The Company carried out an evaluation, under the supervision and with the participation of Management, including the Company's Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company's disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, the Company's Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective as of that date. During the third quarter of 2025, the Company acquired the Signature Management & Power business (Maritime). The Company is currently in the process of integrating Maritime into its assessment of its internal control over financial reporting. In accordance with the SEC's published guidance, Management's assessment, and conclusions on the effectiveness of our disclosure controls and procedures as of June 30, 2025, excludes an assessment of the internal control over financial reporting of Maritime. Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in Company reports filed or submitted under the Securities Exchange Act of 1934 (the "Exchange Act") is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms. Other than as described above with respect to Maritime, there has been no change in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The Company did not repurchase any shares during the third quarter of 2025.

ITEM 5. OTHER INFORMATION

During the third quarter of fiscal 2025, no director or officer (as defined in Securities and Exchange Commission Rule 16-a-1(f)) of the Company adopted or terminated:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Any contract, instruction or written plan for the purchase or sale of Company securities intended to satisfy the affirmative defense conditions of SEC Rule 10b5-1(c) (a "Rule 10b5-1 trading arrangement"); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Any " non-Rule 10-b5-1 trading arrangement" as defined in Item 408(c) of SEC Regulation S-K.

ITEM 6. EXHIBITS

---

| | | |
|:---|:---|:---|
| **Exhibit Number** | **Description** | **Document Location** |
| 3.1(a) | [Restated Articles of Incorporation](https://www.sec.gov/Archives/edgar/data/866706/000095013799004629/0000950137-99-004629.txt) | Exhibit 3(a) to the Company's Form 10-K for the fiscal year ended September 30, 1999 |
| 3.1(b) | [Amended Certificate of Designation, Preferences and Rights of Series A Participating Cumulative Preferred Stock of the Registrant](https://www.sec.gov/Archives/edgar/data/866706/000086670600000007/0000866706-00-000007.txt) | Exhibit 4(e) to the Company's Form 10-Q for the fiscal quarter ended March 31, 2000 |
| 3.1(c) | [Articles of Merger effective July 10, 2000](https://www.sec.gov/Archives/edgar/data/866706/000095013700003733/ex3-c.txt) | Exhibit 3(c) to the Company's Form 10-Q for the fiscal quarter ended June 30, 2000 |
| 3.1(d) | [Amendment of Articles of Incorporation effective February 5, 2018](https://www.sec.gov/Archives/edgar/data/866706/000114420418006155/tv485071_ex3-1.htm) | Exhibit 3.1 to the Company's Form 8-K filed February 7, 2018 |
| 3.2 | [Bylaws](https://www.sec.gov/Archives/edgar/data/866706/000110465922121229/tm2231072d1_ex3-1.htm) | Exhibit 3.1 to the Company's Form 8-K filed November 22, 2022 |
| 4.1(a) | [Amended and Restated Credit Agreement dated August 30, 2023](https://www.sec.gov/Archives/edgar/data/866706/000110465923098463/tm2325206d1_ex10-1.htm) | Exhibit 10.1 to the Company's Form 8-K filed September 6, 2023 |
| 4.1(b) | [Amendment No. 1 to the Amended and Restated Credit Agreement dated August 30, 2023](https://www.sec.gov/Archives/edgar/data/866706/000141057824002064/ese-20240930xex10d1c.htm) | Exhibit 10 (c) to the Company's Form 10-K for the fiscal year ended September 30, 2024 |
| 31.1 | [Certification of Chief Executive Officer](ese-20250630xex31d1.htm) | Filed herewith |
| 31.2 | [Certification of Chief Financial Officer](ese-20250630xex31d2.htm)  | Filed herewith |
| 32 | [Certification of Chief Executive Officer and Chief Financial Officer](ese-20250630xex32.htm) | Filed herewith |
| 101.INS | XBRL Instance Document\* | Submitted herewith |
| 101.SCH | XBRL Schema Document\* | Submitted herewith |
| 101.CAL | XBRL Calculation Linkbase Document\* | Submitted herewith |
| 101.DEF | XBRL Definition Linkbase Document\* | Submitted herewith |
| 101.LAB | XBRL Label Linkbase Document\* | Submitted herewith |
| 101.PRE | XBRL Presentation Linkbase Document\* | Submitted herewith |
| 104 | Cover Page Interactive Data File (contained in Exhibit 101) | Submitted herewith |

---

\* Exhibit 101 to this report consists of documents formatted in XBRL (Extensible Business Reporting Language). The financial information contained in the XBRL – related documents is "unaudited" or "unreviewed".

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
|  | ESCO TECHNOLOGIES INC. |
|  | /s/ Christopher L. Tucker |
|  | Christopher L. Tucker |
|  | Senior Vice President and Chief Financial Officer |
|  | (As duly authorized officer and principal accounting and financial officer of the registrant) |
| Dated: August 11, 2025 |  |

---

## Exhibit 31.1

**Exhibit 31.1**

CERTIFICATION

I, Bryan H. Sayler, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of ESCO Technologies Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 11, 2025

---

| |
|:---|
| /s/ Bryan H. Sayler |
| Bryan H. Sayler |
| President and Chief Executive Officer |

---

------

## Exhibit 31.2

**Exhibit 31.2**

CERTIFICATION

I, Christopher L. Tucker, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of ESCO Technologies Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 11, 2025

---

| |
|:---|
| /s/ Christopher L. Tucker |
| Christopher L. Tucker |
| Senior Vice President and Chief Financial Officer |

---

------

## Ex-32

**Exhibit 32**

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of ESCO Technologies Inc. (the "Company") on Form 10-Q for the period ended June 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Bryan H. Sayler, President and Chief Executive Officer of the Company, and Christopher L. Tucker, Senior Vice President and Chief Financial Officer of the Company, certify, to the best of our knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 11, 2025

---

| |
|:---|
| /s/ Bryan H. Sayler |
| Bryan H. Sayler |
| President and Chief Executive Officer |
| ESCO Technologies Inc. |
| /s/ Christopher L. Tucker |
| Christopher L. Tucker |
| Senior Vice President and Chief Financial Officer |
| ESCO Technologies Inc. |

---

------